How Do Genetic Mutations Influence Cancer Treatment?
The identification of specific genetic mutations can guide personalized treatment approaches. For instance, patients with EGFR mutations in lung cancer may benefit from EGFR inhibitors, while those with KRAS mutations may not. Similarly, PARP inhibitors are effective in cancers with BRCA mutations. This approach, known as precision medicine, tailors treatment based on the genetic profile of the tumor, improving outcomes and reducing side effects.
